Detecting disseminated solid tumor cells in hematopoietic samples

Methodological aspects

G. Méhes, P. F. Ambros, H. Gadner

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Detection of tumor cell dissemination in solid tumor patients recently became essential to determine the prognosis of the disease and to monitor response to the therapy. Accurate detection of disseminated tumor cells in hematological samples requires tumor-specific target molecules, which allow sensitive and specific assays and, further, enable the quantification of tumor cells. Currently, numerous applications are in use, including immunological and molecular biological approaches. Theoretically, both ways are sensitive enough to detect less than one tumor cell in 1 million hematopoietic cells. With the improved sensitivity, however, the likelihood that unspecific events will be amplified is also increased. Moreover, biological and analytical variables may fundamentally influence the findings in a particular case. Basic methods, significant pitfalls and the most recent developments in this field are discussed in this overview.

Original languageEnglish
Pages (from-to)97-109
Number of pages13
JournalHaematologia
Volume31
Issue number2
DOIs
Publication statusPublished - 2001

Fingerprint

Neoplasms
Therapeutics

Keywords

  • Bone marrow
  • Disseminated tumor cells
  • Immunology
  • PCR

ASJC Scopus subject areas

  • Hematology

Cite this

Detecting disseminated solid tumor cells in hematopoietic samples : Methodological aspects. / Méhes, G.; Ambros, P. F.; Gadner, H.

In: Haematologia, Vol. 31, No. 2, 2001, p. 97-109.

Research output: Contribution to journalArticle

@article{eba56f8cac464471935c5abc903bb19e,
title = "Detecting disseminated solid tumor cells in hematopoietic samples: Methodological aspects",
abstract = "Detection of tumor cell dissemination in solid tumor patients recently became essential to determine the prognosis of the disease and to monitor response to the therapy. Accurate detection of disseminated tumor cells in hematological samples requires tumor-specific target molecules, which allow sensitive and specific assays and, further, enable the quantification of tumor cells. Currently, numerous applications are in use, including immunological and molecular biological approaches. Theoretically, both ways are sensitive enough to detect less than one tumor cell in 1 million hematopoietic cells. With the improved sensitivity, however, the likelihood that unspecific events will be amplified is also increased. Moreover, biological and analytical variables may fundamentally influence the findings in a particular case. Basic methods, significant pitfalls and the most recent developments in this field are discussed in this overview.",
keywords = "Bone marrow, Disseminated tumor cells, Immunology, PCR",
author = "G. M{\'e}hes and Ambros, {P. F.} and H. Gadner",
year = "2001",
doi = "10.1163/15685590152492918",
language = "English",
volume = "31",
pages = "97--109",
journal = "Haematologia",
issn = "0017-6559",
publisher = "VSP BV",
number = "2",

}

TY - JOUR

T1 - Detecting disseminated solid tumor cells in hematopoietic samples

T2 - Methodological aspects

AU - Méhes, G.

AU - Ambros, P. F.

AU - Gadner, H.

PY - 2001

Y1 - 2001

N2 - Detection of tumor cell dissemination in solid tumor patients recently became essential to determine the prognosis of the disease and to monitor response to the therapy. Accurate detection of disseminated tumor cells in hematological samples requires tumor-specific target molecules, which allow sensitive and specific assays and, further, enable the quantification of tumor cells. Currently, numerous applications are in use, including immunological and molecular biological approaches. Theoretically, both ways are sensitive enough to detect less than one tumor cell in 1 million hematopoietic cells. With the improved sensitivity, however, the likelihood that unspecific events will be amplified is also increased. Moreover, biological and analytical variables may fundamentally influence the findings in a particular case. Basic methods, significant pitfalls and the most recent developments in this field are discussed in this overview.

AB - Detection of tumor cell dissemination in solid tumor patients recently became essential to determine the prognosis of the disease and to monitor response to the therapy. Accurate detection of disseminated tumor cells in hematological samples requires tumor-specific target molecules, which allow sensitive and specific assays and, further, enable the quantification of tumor cells. Currently, numerous applications are in use, including immunological and molecular biological approaches. Theoretically, both ways are sensitive enough to detect less than one tumor cell in 1 million hematopoietic cells. With the improved sensitivity, however, the likelihood that unspecific events will be amplified is also increased. Moreover, biological and analytical variables may fundamentally influence the findings in a particular case. Basic methods, significant pitfalls and the most recent developments in this field are discussed in this overview.

KW - Bone marrow

KW - Disseminated tumor cells

KW - Immunology

KW - PCR

UR - http://www.scopus.com/inward/record.url?scp=0035207656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035207656&partnerID=8YFLogxK

U2 - 10.1163/15685590152492918

DO - 10.1163/15685590152492918

M3 - Article

VL - 31

SP - 97

EP - 109

JO - Haematologia

JF - Haematologia

SN - 0017-6559

IS - 2

ER -